Clinical Trial Protocol Information

Clinical trial protocol information for active or completed studies are available below.

If you are a patient, physician, or researcher seeking more information about Takeda’s active or completed clinical trials in the Japanese language please click here.


All Clinical Trial Protocol Information

Search

C25007

A Single-arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma Who Are Not Suitable for Stem Cell Transplantation or Multiagent Chemotherapy
www.clinicaltrials.gov/ct2/show/NCT01990534

C16016

A Phase 1 Study of [14C]-MLN9708 to Assess Mass Balance, Pharmacokinetics, and Metabolism in Patients With Advanced Solid Tumors or Lymphomas
www.clinicaltrials.gov/ct2/show/NCT01953783

C16020

An Open-Label, Phase 2 Study to Evaluate the Oral Combination of MLN9708 With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Requiring Systemic Treatment
www.clinicaltrials.gov/ct2/show/NCT02046070

TAK-390MR

A Study to Compare the Efficacy and Safety of TAK-390MR and Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis
www.clinicaltrials.gov/ct/show/NCT00255151

TAK-375 / EC302

A randomised, double-blind, placebo-controlled study to determine the long-term efficacy and safety of ramelteon in adults with chronic insomnia
clinicaltrials.gov/ct2/show/NCT00247390

TAK-128 (TL-003)

TAK-128 Effects on Diabetic Peripheral Neuropathy
clinicaltrials.gov/ct2/show/NCT00229437

SYR-322

Study of SYR-322 Combined With a Sulfonylurea in the Treatment of Type 2 Diabetes
www.clinicaltrials.gov/ct/show/NCT00286468

TAK-390MR

A Study to Compare the Efficacy and Safety of TAK390MR and Placebo in Treating the Symptoms of Gastroesophageal Reflux Disease (GERD)
www.clinicaltrials.gov/ct/show/NCT00251745